Research Peptide Literature Index
Published · Last updated · Publisher: ENOS Labs USA
What is this index?
This index groups every source cited across the ENOS testing guides and compound pages by topic. Each entry links to a specific PubMed, ClinicalTrials.gov or PubChem record that was opened and checked before it was added. Search result pages and unverified citations are excluded, so the list is short by design.
Analytical methods
- HPLC analysis and purification of peptides (PMID 18604941)Methods in Molecular Biology, 2007 · PubMed
- Analysis of synthetic peptides by high-performance liquid chromatography (PMID 9353732)Methods in Enzymology, 1997 · PubMed
- Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control (PMID 25716148)The AAPS Journal, 2015 · PubMed
- Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives (PMID 34110145)Journal of the American Society for Mass Spectrometry, 2021 · PubMed
- Mass spectrometry for protein and peptide characterisation (PMID 11497236)Cellular and Molecular Life Sciences, 2001 · PubMed
- Peptide identification by tandem mass spectrometry with alternate fragmentation modes (PMID 22595789)Molecular & Cellular Proteomics, 2012 · PubMed
- Related impurities in peptide medicines (PMID 25044089)Journal of Pharmaceutical and Biomedical Analysis, 2014 · PubMed
- Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective (PMID 39243929)Regulatory Toxicology and Pharmacology, 2024 · PubMed
Stability and handling
- Factors affecting the physical stability (aggregation) of peptide therapeutics (PMID 29147559)Interface Focus, 2017 · PubMed
- Stability characterization and appearance of particulates in a lyophilized formulation of a model peptide hormone-human secretin (PMID 25636302)International Journal of Pharmaceutics, 2015 · PubMed
IGF-1 LR3
- Detection of His-tagged Long-R3-IGF-I in a black market product (PMID 20675162)Growth Hormone & IGF Research, 2010 · PubMed
- Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion (PMID 8919033)Growth Factors, 1996 · PubMed
- Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects (PMID 7683875)The Biochemical Journal, 1993 · PubMed
BPC-157
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing (PMID 30915550)Cell and Tissue Research, 2019 · PubMed
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing (PMID 34267654)Frontiers in Pharmacology, 2021 · PubMed
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth (PMID 14554208)Journal of Orthopaedic Research, 2003 · PubMed
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (PMID 40756949)HSS Journal, 2025 · PubMed
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (PMID 40789979)Current Reviews in Musculoskeletal Medicine, 2025 · PubMed
- BPC 157 compound record (PubChem CID 9941957)PubChem · NIH National Library of Medicine
TB-500
- Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues (PMID 16099219)Trends in Molecular Medicine, 2005 · PubMed
- Thymosin beta 4 and the eye: the journey from bench to bedside (PMID 30063853)Expert Opinion on Biological Therapy, 2018 · PubMed
- Thymosin beta-4 compound record (PubChem CID 45382195)PubChem · NIH National Library of Medicine
GHK-Cu
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (PMID 29986520)International Journal of Molecular Sciences, 2018 · PubMed
- The human tri-peptide GHK and tissue remodeling (PMID 18644225)Journal of Biomaterials Science, Polymer Edition, 2008 · PubMed
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (PMID 26236730)BioMed Research International, 2015 · PubMed
- Prezatide copper (GHK copper) compound record (PubChem CID 71587328)PubChem · NIH National Library of Medicine
Retatrutide
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial (PMID 37366315)The New England Journal of Medicine, 2023 · PubMed
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA (PMID 37385280)The Lancet, 2023 · PubMed
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial (PMID 38858523)Nature Medicine, 2024 · PubMed
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (PMID 42814954)The New England Journal of Medicine, 2026 · PubMed
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (NCT05929066)ClinicalTrials.gov · NIH National Library of Medicine
MOTS-c
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (PMID 25738459)Cell Metabolism, 2015 · PubMed
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (PMID 33473109)Nature Communications, 2021 · PubMed
- MOTS-c: A Mitochondrial-Encoded Regulator of the Nucleus (PMID 31378979)BioEssays, 2019 · PubMed
- MOTS-c compound record (PubChem CID 146675088)PubChem · NIH National Library of Medicine
SS-31 (Elamipretide)
- The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin (PMID 23813215)Journal of the American Society of Nephrology, 2013 · PubMed
- First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics (PMID 24117165)British Journal of Pharmacology, 2014 · PubMed
- Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial (PMID 37268435)Neurology, 2023 · PubMed
- Elamipretide: First Approval (PMID 41335372)Drugs, 2026 · PubMed
- A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension (NCT03323749)ClinicalTrials.gov · NIH National Library of Medicine
- Elamipretide compound record (PubChem CID 11764719)PubChem · NIH National Library of Medicine
CJC-1295
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults (PMID 16352683)The Journal of Clinical Endocrinology & Metabolism, 2006 · PubMed
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog (PMID 17018654)The Journal of Clinical Endocrinology & Metabolism, 2006 · PubMed
- CJC-1295 compound record (PubChem CID 91971820)PubChem · NIH National Library of Medicine
Ipamorelin
- Ipamorelin, the first selective growth hormone secretagogue (PMID 9849822)European Journal of Endocrinology, 1998 · PubMed
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers (PMID 10496658)Pharmaceutical Research, 1999 · PubMed
- Ipamorelin compound record (PubChem CID 9831659)PubChem · NIH National Library of Medicine
Tesamorelin
- Metabolic effects of a growth hormone-releasing factor in patients with HIV (PMID 18057338)The New England Journal of Medicine, 2007 · PubMed
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy (PMID 21668043)Drugs, 2011 · PubMed
- TH9507 in Patients With HIV-Associated Lipodystrophy (NCT00435136)ClinicalTrials.gov · NIH National Library of Medicine
- Tesamorelin compound record (PubChem CID 16137828)PubChem · NIH National Library of Medicine
Sermorelin
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency (PMID 18031173)BioDrugs, 1999 · PubMed
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? (PMID 18046908)Clinical Interventions in Aging, 2006 · PubMed
- Sermorelin compound record (PubChem CID 16132413)PubChem · NIH National Library of Medicine
NAD+
- NAD+ in aging, metabolism, and neurodegeneration (PMID 26785480)Science, 2015 · PubMed
- NAD(+) metabolism and its roles in cellular processes during ageing (PMID 33353981)Nature Reviews Molecular Cell Biology, 2021 · PubMed
- Nicotinamide adenine dinucleotide compound record (PubChem CID 5892)PubChem · NIH National Library of Medicine
SLU-PP-332
- Synthetic ERRalpha/beta/gamma Agonist Induces an ERRalpha-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity (PMID 36988910)ACS Chemical Biology, 2023 · PubMed
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome (PMID 37739806)The Journal of Pharmacology and Experimental Therapeutics, 2024 · PubMed
- In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential (PMID 41588687)Rapid Communications in Mass Spectrometry, 2026 · PubMed
- SLU-PP-332 compound record (PubChem CID 5338394)PubChem · NIH National Library of Medicine
5-Amino-1MQ
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice (PMID 29155147)Biochemical Pharmacology, 2018 · PubMed
- Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle (PMID 30753815)Biochemical Pharmacology, 2019 · PubMed
- Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice (PMID 33707534)Scientific Reports, 2021 · PubMed
- 5-Amino-1-methylquinolinium compound record (PubChem CID 950107)PubChem · NIH National Library of Medicine
To continue, see the peptide testing hub, the compound directory, how to read a certificate of analysis and the peptide testing glossary.
For Research Use Only
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.